Edge Medical Ventures
- Company typePrivate
- Founded2024
- HeadquartersOr Yehuda, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
Edge Medical Ventures firmographics
Firmographics- Name
- Edge Medical Ventures
- Legal name
- Edge Medical Ventures
- Website
- https://edgemed.vc
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Edge Medical Ventures industry classification
Industry- Product category
- Medical Technology Venture Capital
- NAICS
- Portfolio Management and Investment Advice (523940)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Healthcare & Life Sciences Growth Equity (FSANACAB)
Keywords
Where Edge Medical Ventures is headquartered
LocationHeadquarters
- HQ city
- Or Yehuda
- HQ country
- Israel
- HQ region
- Middle East
Offices2 records
Markets served
Edge Medical Ventures business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Revenue model
- Investment Returns / Equity Participation: As a venture capital fund, Edge Medical Ventures generates returns through equity ownership in portfolio companies, benefiting from capital appreciation and exit events such as acquisitions or IPOs.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Edge Medical Ventures product offering
Product offeringCore offering
Edge Medical Ventures is a medtech-focused venture studio and fund that operates a dual structure: EdgeLabs, a venture creation studio that builds medical device companies from validated unmet clinical needs identified by strategic collaborators, and EdgeMED, a venture capital fund that invests up to $3M per round in seed, Series A, and early Series B stages primarily at the clinical stage. The firm focuses on bridging Israeli medical device innovation to the U.S. market by providing capital, clinical operations guidance, commercial launch preparation, and access to U.S. healthcare systems and investors.
Product overview
Edge Medical Ventures operates as a medtech-focused venture studio and fund with a dual structure: EdgeLabs (venture creation studio) and EdgeMED (venture capital fund). The company bridges Israeli innovation with the U.S. market, supporting portfolio companies through clinical operations, commercial launch preparation, and networking with healthcare systems. The portfolio includes six medical device companies: Exero Medical (early detection of postoperative anastomotic leaks using the xBar system), Synchrony Medical (LibAirty airway clearance system for respiratory care with FDA clearance), PatenSee (AI-driven hemodialysis monitoring with FDA Breakthrough Designation), Append Medical (transseptal LAA closure system), and Lifecord (mitral chordal repair system).
Differentiator
Problem solved
Functional benefit
Brands
- EdgeMED: Later-stage venture capital fund that typically invests in seed, Series A, and early Series B rounds (up to $3M) primarily at the clinical stage.
- EdgeLabs
Products and services
- EdgeLabs Venture Creation Studio Venture creation studio that starts from unmet needs posed by strategic collaborators to build medtech companies from the ground up; provides operational and clinical support to spin out new ventures. Targeted at clinicians, strategic collaborators, and entrepreneurs with validated unmet clinical needs.
- EdgeMED Venture Capital Fund Venture capital fund that invests in medical device companies at seed, Series A, and early Series B stages, primarily at the clinical stage, with typical investment sizes up to $3M. Targeted at early-stage clinical-stage medtech companies seeking capital and operational support for Israel-to-U.S. market transition.
Companies that use Edge Medical Ventures
Customer profileSegments1 record
Ideal customer profiles1 record
Edge Medical Ventures technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Edge Medical Ventures partnerships and signals
Strategic signalPartnerships
Four partnerships are on record, tiered core.
- ARC at Sheba Medical CentercoreStrategic partnership to develop medical device and bio-convergence startups, leveraging previous successful collaborations and clinical insights. Combines open and organic innovation to create healthcare solutions addressing unmet clinical needs. Supported by investment from the Israel Innovation Authority.
- New Jersey Economic Development Authority (NJEDA)corePartnership to promote Israeli-developed medical devices in the U.S. market with focus on local job creation and ecosystem diversification. Supports Israeli startups like Synchrony Medical expanding U.S. sales. Includes co-investment through New Jersey Innovation Evergreen Fund.
- MEDX XeleratorcoreEdge Medical Ventures was founded by the leadership team of MEDX Xelerator, Israel's leading medical device incubator. Since 2018, MEDX has launched and invested in 18 medical device companies. Edge extends the lifecycle of support that began at MEDX.
- Sheba Medical CentercoreMajor Israeli medical center collaborating with Edge Medical Ventures on portfolio company development. Synchrony Medical developed its device in collaboration with pulmonologists at Sheba Medical Center.
Scale indicators4 records
Recent moves6 records
Expansion highlights5 records
Edge Medical Ventures competitors and assessment
Company assessmentBroad incumbents
- OurCrowd: Large Israeli venture platform with a significant healthcare/medtech portfolio. Broader and more diversified than Edge, but competes for the same Israeli early-stage medtech deal flow.
- NFX: Israel/US-based venture firm with a network-driven pre-seed and seed model. Not a medtech specialist but operates in the same Israeli early-stage ecosystem as Edge.
- Pitango Venture Capital: One of Israel's largest venture capital firms with a dedicated healthtech practice. A broad incumbent competitor for Israeli healthcare deal flow at all stages.
- Jerusalem Venture Partners (JVP): Established Israeli VC with active digital health and medtech investing. A larger, more generalist incumbent that overlaps with Edge on Israeli healthtech opportunities.
Direct peers
- Triventures: Israel-based venture fund focused on medical devices and digital health. Closely comparable mandate (early-stage medtech) and geographic footprint to Edge.
- Accelmed: Medical device-focused venture capital firm with strong Israeli ties. Comparable as a specialist early- and growth-stage medtech investor with similar portfolio construction approach.
- aMoon Ventures: Israeli healthtech and digital health venture fund. Directly comparable to Edge as an Israel-based investor focused on early- and growth-stage healthcare innovation.
- Peregrine Ventures: Israel-based venture capital firm investing in medical devices and healthcare technology. Comparable in stage, sector focus, and Israeli ecosystem orientation to Edge.
- MEDX Xelerator: Israel's leading medical device incubator, founded by the same leadership team as Edge Medical Ventures. Direct predecessor and ongoing pipeline source for Edge's portfolio and venture studio (EdgeLabs).
- ALIVE Israel Health Tech Fund: Israeli venture fund dedicated to early-stage health tech and medical devices. Closely comparable in sector focus, stage, and Israeli geographic concentration to Edge.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Edge Medical Ventures social profiles
Digital presenceEdge Medical Ventures financial estimates
Financial estimateRevenue estimate
Valuation estimate
Edge Medical Ventures leadership team
Management profileNumber of profiles
Profiles7 records
Edge Medical Ventures funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Edge Medical Ventures M&A and investment
M&A and investmentM&A
Investments5 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Edge Medical Ventures
What does Edge Medical Ventures do?
Edge Medical Ventures is a medtech-focused venture studio and fund that operates a dual structure: EdgeLabs, a venture creation studio that builds medical device companies from validated unmet clinical needs identified by strategic collaborators, and EdgeMED, a venture capital fund that invests up to $3M per round in seed, Series A, and early Series B stages primarily at the clinical stage. The firm focuses on bridging Israeli medical device innovation to the U.S. market by providing capital, clinical operations guidance, commercial launch preparation, and access to U.S. healthcare systems and investors.
Is Edge Medical Ventures a public or private company?
Edge Medical Ventures is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Edge Medical Ventures founded?
Edge Medical Ventures was founded in 2024. It employs 1 to 10 people.
Where is Edge Medical Ventures based?
Edge Medical Ventures is headquartered in Or Yehuda, Israel, in the Middle East region.
How does Edge Medical Ventures make money?
One revenue line is on record: investment Returns / Equity Participation.
Who are Edge Medical Ventures's main competitors?
Broad incumbents on record are OurCrowd, NFX, Pitango Venture Capital and Jerusalem Venture Partners (JVP). Direct peers are Triventures, Accelmed, aMoon Ventures, Peregrine Ventures, MEDX Xelerator and ALIVE Israel Health Tech Fund.
Does Edge Medical Ventures have an API?
No public API is recorded for Edge Medical Ventures.
What industry is Edge Medical Ventures in?
Edge Medical Ventures's product category is Medical Technology Venture Capital. Its primary akta.pro industry code is FSANACAB, Healthcare & Life Sciences Growth Equity. Its NAICS code is 523940 and its SIC code is 6282.